New

Glaucoma Therapeutics Market

2021

Glaucoma Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic Anhydrase Inhibitors, Combination Medications, Cholinergics); End Use (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) and Geography

| Report Code: TIPRE00018828 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Glaucoma Therapeutics Market 2028 By Drug Class, End Use and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Glaucoma is a type of eye condition that damage optic nerve, the health of optic nerve is very crucial for clear vision. Glaucoma usually occurs by abnormal high pressure (Intraocular pressure) in the eye. Glaucoma can affect people of any age but is common in elderly population. The symptoms of glaucoma include, patchy blind spot, severe headache, blurred vision, eye redness. Glaucoma therapeutics are the agents which used in management of glaucoma.

MARKET DYNAMICS

The key market drivers for Glaucoma Therapeutics Market Includes, rising geriatric population across the globe along with increasing incidences of glaucoma across the globe. Moreover, high R&D investments by pharma companies to develop novel therapies for maintaining strong pipeline of therapeutic agents is also expected to fuel market growth. Additionally, rising healthcare expenditure is also expected to boost market growth. Whereas, side effects from drug therapies along with drug recalls by major players is expected to restrain market growth.

MARKET SCOPE

The "Glaucoma Therapeutics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glaucoma Therapeutics market with detailed market segmentation by drug class and end use. The Glaucoma Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Glaucoma Therapeutics Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Glaucoma Therapeutics Market is segmented on the basis of drug class and end use. On the basis of drug class the market is segmented as, prostaglandins, beta blockers, alpha agonists, carbonic anhydrase inhibitors, cholinergic. And on the basis of end use the market is segmented as, hospitals, ophthalmic clinics, and ambulatory surgical centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Glaucoma Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glaucoma Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Glaucoma Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glaucoma Therapeutics Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Glaucoma Therapeutics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glaucoma Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Glaucoma Therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Glaucoma Therapeutics Market.

The report also includes the profiles of key players in Glaucoma Therapeutics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Merck and Co, Inc.
- Allergan Plc.
- Bausch and Lomb Incorporated
- Teva Pharmaceuticals
- Valeant Pharmaceuticals
- Santen Pharmaceuticals
- Aerie Pharmaceuticals
- Aristo Pharmaceuticals
- Novartis AG
- Pfizer, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glaucoma Therapeutics Market - By Drug Class
1.3.2 Glaucoma Therapeutics Market - By End Use
1.3.3 Glaucoma Therapeutics Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GLAUCOMA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. GLAUCOMA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GLAUCOMA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. GLAUCOMA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. GLAUCOMA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GLAUCOMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. PROSTAGLANDINS
7.3.1. Overview
7.3.2. Prostaglandins Market Forecast and Analysis
7.4. BETA BLOCKERS
7.4.1. Overview
7.4.2. Beta Blockers Market Forecast and Analysis
7.5. ALPHA AGONISTS
7.5.1. Overview
7.5.2. Alpha Agonists Market Forecast and Analysis
7.6. CARBONIC ANHYDRASE INHIBITORS
7.6.1. Overview
7.6.2. Carbonic Anhydrase Inhibitors Market Forecast and Analysis
7.7. COMBINATION MEDICATIONS
7.7.1. Overview
7.7.2. Combination Medications Market Forecast and Analysis
7.8. CHOLINERGICS
7.8.1. Overview
7.8.2. Cholinergics Market Forecast and Analysis
8. GLAUCOMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. OPHTHALMIC CLINICS
8.4.1. Overview
8.4.2. Ophthalmic Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis

9. GLAUCOMA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Glaucoma Therapeutics Market Overview
9.1.2 North America Glaucoma Therapeutics Market Forecasts and Analysis
9.1.3 North America Glaucoma Therapeutics Market Forecasts and Analysis - By Drug Class
9.1.4 North America Glaucoma Therapeutics Market Forecasts and Analysis - By End Use
9.1.5 North America Glaucoma Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Glaucoma Therapeutics Market
9.1.5.1.1 United States Glaucoma Therapeutics Market by Drug Class
9.1.5.1.2 United States Glaucoma Therapeutics Market by End Use
9.1.5.2 Canada Glaucoma Therapeutics Market
9.1.5.2.1 Canada Glaucoma Therapeutics Market by Drug Class
9.1.5.2.2 Canada Glaucoma Therapeutics Market by End Use
9.1.5.3 Mexico Glaucoma Therapeutics Market
9.1.5.3.1 Mexico Glaucoma Therapeutics Market by Drug Class
9.1.5.3.2 Mexico Glaucoma Therapeutics Market by End Use
9.2. EUROPE
9.2.1 Europe Glaucoma Therapeutics Market Overview
9.2.2 Europe Glaucoma Therapeutics Market Forecasts and Analysis
9.2.3 Europe Glaucoma Therapeutics Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Glaucoma Therapeutics Market Forecasts and Analysis - By End Use
9.2.5 Europe Glaucoma Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Glaucoma Therapeutics Market
9.2.5.1.1 Germany Glaucoma Therapeutics Market by Drug Class
9.2.5.1.2 Germany Glaucoma Therapeutics Market by End Use
9.2.5.2 France Glaucoma Therapeutics Market
9.2.5.2.1 France Glaucoma Therapeutics Market by Drug Class
9.2.5.2.2 France Glaucoma Therapeutics Market by End Use
9.2.5.3 Italy Glaucoma Therapeutics Market
9.2.5.3.1 Italy Glaucoma Therapeutics Market by Drug Class
9.2.5.3.2 Italy Glaucoma Therapeutics Market by End Use
9.2.5.4 Spain Glaucoma Therapeutics Market
9.2.5.4.1 Spain Glaucoma Therapeutics Market by Drug Class
9.2.5.4.2 Spain Glaucoma Therapeutics Market by End Use
9.2.5.5 United Kingdom Glaucoma Therapeutics Market
9.2.5.5.1 United Kingdom Glaucoma Therapeutics Market by Drug Class
9.2.5.5.2 United Kingdom Glaucoma Therapeutics Market by End Use
9.2.5.6 Rest of Europe Glaucoma Therapeutics Market
9.2.5.6.1 Rest of Europe Glaucoma Therapeutics Market by Drug Class
9.2.5.6.2 Rest of Europe Glaucoma Therapeutics Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Glaucoma Therapeutics Market Overview
9.3.2 Asia-Pacific Glaucoma Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Glaucoma Therapeutics Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Glaucoma Therapeutics Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Glaucoma Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Glaucoma Therapeutics Market
9.3.5.1.1 Australia Glaucoma Therapeutics Market by Drug Class
9.3.5.1.2 Australia Glaucoma Therapeutics Market by End Use
9.3.5.2 China Glaucoma Therapeutics Market
9.3.5.2.1 China Glaucoma Therapeutics Market by Drug Class
9.3.5.2.2 China Glaucoma Therapeutics Market by End Use
9.3.5.3 India Glaucoma Therapeutics Market
9.3.5.3.1 India Glaucoma Therapeutics Market by Drug Class
9.3.5.3.2 India Glaucoma Therapeutics Market by End Use
9.3.5.4 Japan Glaucoma Therapeutics Market
9.3.5.4.1 Japan Glaucoma Therapeutics Market by Drug Class
9.3.5.4.2 Japan Glaucoma Therapeutics Market by End Use
9.3.5.5 South Korea Glaucoma Therapeutics Market
9.3.5.5.1 South Korea Glaucoma Therapeutics Market by Drug Class
9.3.5.5.2 South Korea Glaucoma Therapeutics Market by End Use
9.3.5.6 Rest of Asia-Pacific Glaucoma Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Glaucoma Therapeutics Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Glaucoma Therapeutics Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Glaucoma Therapeutics Market Overview
9.4.2 Middle East and Africa Glaucoma Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Glaucoma Therapeutics Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Glaucoma Therapeutics Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Glaucoma Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Glaucoma Therapeutics Market
9.4.5.1.1 South Africa Glaucoma Therapeutics Market by Drug Class
9.4.5.1.2 South Africa Glaucoma Therapeutics Market by End Use
9.4.5.2 Saudi Arabia Glaucoma Therapeutics Market
9.4.5.2.1 Saudi Arabia Glaucoma Therapeutics Market by Drug Class
9.4.5.2.2 Saudi Arabia Glaucoma Therapeutics Market by End Use
9.4.5.3 U.A.E Glaucoma Therapeutics Market
9.4.5.3.1 U.A.E Glaucoma Therapeutics Market by Drug Class
9.4.5.3.2 U.A.E Glaucoma Therapeutics Market by End Use
9.4.5.4 Rest of Middle East and Africa Glaucoma Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Glaucoma Therapeutics Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Glaucoma Therapeutics Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Glaucoma Therapeutics Market Overview
9.5.2 South and Central America Glaucoma Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Glaucoma Therapeutics Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Glaucoma Therapeutics Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Glaucoma Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Glaucoma Therapeutics Market
9.5.5.1.1 Brazil Glaucoma Therapeutics Market by Drug Class
9.5.5.1.2 Brazil Glaucoma Therapeutics Market by End Use
9.5.5.2 Argentina Glaucoma Therapeutics Market
9.5.5.2.1 Argentina Glaucoma Therapeutics Market by Drug Class
9.5.5.2.2 Argentina Glaucoma Therapeutics Market by End Use
9.5.5.3 Rest of South and Central America Glaucoma Therapeutics Market
9.5.5.3.1 Rest of South and Central America Glaucoma Therapeutics Market by Drug Class
9.5.5.3.2 Rest of South and Central America Glaucoma Therapeutics Market by End Use

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. GLAUCOMA THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. MERCK AND CO, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NOVARTIS AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALLERGAN PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAUSCH AND LOMB INCORPORATED
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TEVA PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. VALEANT PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANTEN PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. AERIE PHARMACEUTICALS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ARISTO PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Merck and Co, Inc
2. Novartis AG
3. Allergan plc
4. Bausch and Lomb Incorporated
5. Teva Pharmaceuticals
6. Pfizer, Inc
7. Valeant Pharmaceuticals
8. Santen Pharmaceuticals
9. Aerie Pharmaceuticals
10. Aristo Pharmaceuticals
TIPRE00018828
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.